Bearish flow noted in Verve Therapeutics (VERV) with 4,217 puts trading, or 1.1x expected. Most active are Nov-25 10 puts and Aug-25 11 puts, with total volume in those strikes near 3,600 contracts. The Put/Call Ratio is 31.24, while ATM IV is up nearly 2 points on the day. Earnings are expected on August 14th.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VERV:
- JonesResearch lists factors for Prime Medicine continued share rally
- Hold Rating Issued for Verve Therapeutics Amid Eli Lilly Acquisition and Uncertain Milestones
- Verve Therapeutics downgraded to Market Perform from Outperform at BMO Capital
- Crispr posts strong CTX310 data, says Chardan
- Eli Lilly (LLY) Enters Gene-Editing Space with Verve Therapeutics Acquisition